Liver transplant anesthesia: An update

Current Opinion in Organ Transplantation

Volumn 8, Issue 3, 2003, Pages 252-257

  Ayoub, Tawfik ^a   Ahmed, Kabir ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Liver transplant; Methylene blue; Nitric oxide

Indexed keywords

EID: 77950074231     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/00075200-200309000-00007     Document Type: Review

References (50)

1. Starzl TE, Demetris AJ, Van Thiel D: Liver transplantation (1). N Engl J Med 1989, 321:1014-1022.
2. Starzl TE, Demetris AJ, Van Thiel D: Liver transplantation (2). N Engl J Med 1989, 321:1092-1099.
3. Starzl TE, Demetris AJ: Liver transplantation: a 31-year perspective. Part I. Curr Probl Surg 1990, 27:49-116.
4. Starzl TE, Demetris AJ: Liver transplantation: a 31-year perspective. Part II. Curr Probl Surg 1990, 27:117-178.
5. Starzl TE, Demetris AJ: Liver transplantation: a 31-year perspective. Part III. Curr Probl Surg 1990, 27:181-240.
6. 2000 Annual report of the Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data 1989-1998. Richmond, VA: United Network of Organ Sharing, February 2001.
7. Cohen B: Wight C: A European perspective on organ procurement: breaking down the barriers to organ donation. Transplantation 1999, 68:985-990.
8. Organ Procurement and Transplantation Network: Data. Available at: http://www.optn.org/latestData/rptData.asp. Accessed May 21, 2003.
9. Wiesner R, Edwards E, Freeman R, et al.: United Network of Organ Sharing liver disease severity score committee: Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003, 124:251-254.
10. Aggarwal S, Kang Y, Freeman JA, et al.: Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc 1987, 19:54-55.
11. William JW, Vera S, Peters TG, et al.: Choletatic jaundice after hepatic transplantation: a nonimmunologically mediated even. Am J Surg 1986, 151:65-70.
12. Webster NR, Bellamy MC, Lodge JP, et al.: Haemodynamics of liver perfusion: comparision of two anesthestic techniques. Br J Anaesth 1994, 72:418-421.
13. Bellamy MC, Galley HF, Webster NR: Changes in inflammatory mediators during orthoptic liver transplantation. Br J Anaesth 1997, 79:338-341.
14. Kuo PC, Abe K, Schroeder RA: Superoxide enhances interleukin 1[beta]- mediated transcription of the hepatocyte-inducible nitric oxide synthase gene. Gastroenterology 2000, 118:608-618.
15. Shah V, Haddad FG, Garcia-Cardena G, et al.: Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest 1997, 100:2923-2930.
16. Koelzow H, Gedney J, Baumann J, et al.: The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthoptic liver transplantation. Anesth Analg 2002, 94:824-829.
17. Mayer B, Brunner F, Schmidt K: Inhibition of nitric oxide synthesis by methylene blue. Biochem Parmacol 1993, 2:16-19.
18. Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43:109-142.
19. Schmidt HH, Lohmann SM, Walter U: The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta 1993, 1178:153-175.
20. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 1992, 6:3051-3064.
21. Bartosz G: Peroxynitrite: Mediator of the toxic action of nitric oxide. Acta Biochim Pol 1996, 43:645-659.
22. Mittal MK, Gupta TK, Lee FY, et al.: Nitric oxide modulates hepatic vascular tone in normal rat liver. Am J Physiol 1994, 267:G416-G22.
23. Sugioka A, Morita M, Esaki T, et al.: Kinetics and significance of graft tissue nitric oxide after rat and mouse liver transplantation. Transplant Proc 1999, 31:860-862.
24. Romero M, Garcia-Monzon C, Clemente G, et al.: Intrahepatic expression of inducible nitric oxide synthase in acute liver allograft rejection: evidence of modulation by corticosteroids. Liver Transpl 2001, 7:16-21.
25. Laugrehr JM, Hoffman RA, Billiar TR, et al.: Nitric oxide synthesis in vivo allograft response: a possible regulatory mechanism. Surgery 1991, 110:335-342.
26. Kuo PC, Slivka A: Nitric oxide decreases oxidant-mediated hepatocyte injury. J Surg Res 1994, 56:594-600.
27. Kohen T, Inal M: The effect of nitric oxide on ischemia-perfusion injury in rat liver. Clin Chim Acta 1999, 288:55-62.
28. Hon WM, Lee KH, Khoo HW: Nitric oxide in liver diseases: friend, foe, or just passerby? Annals of the NY Academy of Sciences 2002, 962:275-295.
29. Virji MA, Aggarwal S, Kang Y: Alterations in plasminogen activator and plasminogen inhibitor level during transplantation. Transplant Proc 1989, 21:3540-3541.
30. Riess H, Jochum M, Machleidt W, et al.: Possible role of extracellularly released phagocyte proteinases in coagulation disorder during liver transplantation. Transplantation 1991, 51:482-490.
31. Kang Y, Lewis JH, Navalgund A, et al.: Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology 1987, 66:766-773.
32. Marcel RJ, Stegall WC, Suit CT, et al.: Continuous small-dose aprotinin controls fibrinolysis during orthoptic liver transplantation. Anesthesia & Analgesia 1996, 82:1122-1125.
33. Kaspar M, Ramsay MA, Nguyen AT, et al.: Continuous small-dose traneximic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation. Anesth Analg 1997, 85:281-285.
34. Boylan JF, Klinck JR, Sandler AN, et al.: Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthoptic liver transplantation. Anesthesiology 1996, 85:1043-1048.
35. Dalmau A, Sabate A, Acosta F, et al.: Tranexamic acid reduces red cell transfusion better than [epsilon]-aminocaproic acid or placebo in liver transplantation. Anesth Analg 2000, 91:29-34.
36. Yanagisawa M, Kurihara H, Kimura S, et al.: A novel potent vasoconstriction peptide produced by vascular endothelial cells. Nature 1988, 332:411-415.
37. Zhang JX, Pegoli W, Clemens MG: Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol 1994, 266:G624-G632.
38. Goto M, Takei Y, Kawano S, et al.: Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances. Hepatol 1994, 19:675-681.
39. Garcia-Pagan JC, Zhang JX, Sonin N, et al.: Ischemia/reperfusion induces an increase in the hepatic portal vasoconstrictive response of endothelin-1. Shock 1999, 11:325-329.
40. Goligorsky MS, Abedi H, Noiri E, et al.: Nitric oxide modulation of focal adhesions in endothelial cells. Am J Physiol 1999, 276:C1271-C1281.
41. Henderson JM, Gilmore GT, Mackay GJ, et al.: Hemodynamics during liver transplantation: the interactions between cardiac output and portal venous and hepatic arterial flows. Hepatology 1992, 16:715.
42. Lautt W: Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic artery buffer response. Am J Physiol 1985, 249:G549.
43. Jakab F, Rath Z, Schmal F, et al.: The interaction between hepatic and portal arterial blood flows; simultaneous measurement by transit time ultrasonic volume flowmetry. Hepatologastroenterology 1995, 42:18.
44. Zoli M, Magalotti D, Bianchi G, et al.: Functional hepatic flow and Dopplerassessed total hepatic flow in control subjects and patients with cirrhosis. J Hepatol 1995, 23:129.
45. Houssin D, Fratacci M, Dupuy P, et al.: One week of monitoring of portal blood flow after liver transplantation using implantable pulsed doppler microprobes. Transplant Proc 1989, 21:2777.
46. Henderson J, Mackay G, Hooks M, et al.: High cardiac output of advanced liver disease persists after orthoptic liver transplantation. Hepatol 1992, 15:258.
47. Hadengue A, Labrec D, Moreau R, et al.: Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients. Hepatol 1993, 17:176.
48. Piscaglia F, Zironi G, Gaiani S, et al.: Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study. Hepatol 1999, 3058.
49. Marcos a, Olzinski A, Ham J, et al.: The interrelationship between portal and arterial blood flow after adult to adult living donor liver transplantation. Transplantation 2000, 70:1797-1803.
50. Hatano E, Terajima H, Yabe S, et al.: Hepatic artery thrombosis in living related liver transplantation. Transplantation 1997, 64:1443-1446